<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Use of medication nebulizers in children
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Use of medication nebulizers in children
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Use of medication nebulizers in children
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Robert H Moore, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Gregory Redding, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Robert A Wood, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Elizabeth TePas, MD, MS
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Dec 06, 2021.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The delivery of aerosolized medication is an important component of treatment for many respiratory disorders in children. Glucocorticoids, bronchodilators, antibiotics, mucus hydration agents, and mucolytic agents can be administered via aerosol.
        </p>
        <p>
         Nebulizer devices are widely used to deliver aerosol therapy, especially in children. A wide variety of nebulizers are available for use in the home and hospital, with varying capacities to deliver drugs to the lungs [
         <a href="#rid1">
          1
         </a>
         ]. Clinicians must consider how a particular nebulizer performs with the specific drug to be administered to ensure its clinical suitability [
         <a href="#rid1">
          1-4
         </a>
         ].
        </p>
        <p>
         The use of medication in nebulizers for children is presented here. An overview of aerosolized medication delivery in children and the use of pressurized metered dose inhalers are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5737.html" rel="external">
          "Delivery of inhaled medication in children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5738.html" rel="external">
          "The use of inhaler devices in children"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          INDICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nebulizers are used to provide aerosol therapy to patients too ill or too young to use handheld devices and in situations where large drug doses are necessary. These devices also are required for some medications available only in liquid form, including
         <a class="drug drug_pediatric" data-topicid="12690" href="/z/d/drug information/12690.html" rel="external">
          pentamidine
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="12764" href="/z/d/drug information/12764.html" rel="external">
          ribavirin
         </a>
         , DNAase, hypertonic
         <a class="drug drug_pediatric" data-topicid="12796" href="/z/d/drug information/12796.html" rel="external">
          saline
         </a>
         , and
         <a class="drug drug_pediatric" data-topicid="12845" href="/z/d/drug information/12845.html" rel="external">
          tobramycin
         </a>
         .
        </p>
        <p>
         The potential benefits of nebulizers need to be balanced with the disadvantages associated with the use of these devices. These include higher costs, longer set-up and delivery time, decreased portability, variable nebulizer performance, and (with jet nebulizers) the need for a source of compressed air or oxygen.
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          BASIC TYPES OF NEBULIZERS
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are three types of nebulizers: jet nebulizers, ultrasonic nebulizers, and vibrating mesh (membrane) nebulizers. There are differences in performance among these types of nebulizers and also among nebulizers of the same type produced by various manufacturers. These differences have potential clinical implications [
         <a href="#rid5">
          5,6
         </a>
         ]. Jet nebulizers are the most frequently used form of nebulizer in the clinical setting. The advantages and disadvantages of the jet [
         <a href="#rid7">
          7-10
         </a>
         ], ultrasonic [
         <a href="#rid7">
          7,9
         </a>
         ], and mesh [
         <a href="#rid11">
          11,12
         </a>
         ] nebulizers are reviewed in the table  (
         <a class="graphic graphic_table graphicRef64982" href="/z/d/graphic/64982.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Jet nebulizers
         </span>
         <span class="headingEndMark">
          —
         </span>
         Jet nebulizers utilize a driving gas of compressed air or oxygen through a jet, creating a negative pressure, which entrains large aerosolized liquid droplets into the gas stream. These particles then are reduced in size by their impaction upon internal baffles, resulting in the generation of smaller, respirable particles of 1 to 5 microm in size [
         <a href="#rid7">
          7-10
         </a>
         ]. Aerosolized medication then is delivered through a patient interface, usually a mouthpiece or facemask  (
         <a class="graphic graphic_figure graphicRef75397" href="/z/d/graphic/75397.html" rel="external">
          figure 1
         </a>
         ). Most aerosolized medications are best delivered by this method of nebulization.
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Ultrasonic nebulizers
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ultrasonic nebulizers consist of a power unit and transducer, with or without an electric fan. Electrical energy from the power unit is converted to high-frequency (1.63 megahertz) ultrasonic waves by a piezoelectric element in the transducer [
         <a href="#rid7">
          7,9
         </a>
         ]. These ultrasonic waves are transmitted to the surface of the solution to create an aerosol. A fan is used to deliver the aerosol to the patient, or the aerosol is evacuated from the nebulization chamber by the inspiratory flow of the patient. Small-volume ultrasonic nebulizers are commercially available for delivery of inhaled bronchodilators. Large-volume ultrasonic nebulizers are used for sputum induction.
        </p>
        <p class="headingAnchor" id="H383507745">
         <span class="h2">
          Vibrating mesh nebulizers
         </span>
         <span class="headingEndMark">
          —
         </span>
         Mesh nebulizers use a perforated membrane to generate the aerosol  (
         <a class="graphic graphic_figure graphicRef69736" href="/z/d/graphic/69736.html" rel="external">
          figure 2
         </a>
         ). Electronic nebulizers can generate aerosolized particles that are highly uniform and respirable (mass median diameter of 3.6 +/- 0.1 microm) and deliver drugs in less than five minutes [
         <a href="#rid11">
          11,12
         </a>
         ]. Other available vibrating mesh nebulizers include the Aeroneb, MicroAIR/NE-U22, and the I-neb. (See
         <a class="medical medical_review" href="/z/d/html/5737.html" rel="external">
          "Delivery of inhaled medication in children", section on 'Aerosol properties'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h1">
          FACTORS AFFECTING JET NEBULIZER PERFORMANCE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Jet nebulizers are the most commonly used type of nebulizer in most countries because of their lower cost and other considerations described above. An effective nebulizer should deliver at least 50 percent of the total dose as respirable aerosol within 10 minutes [
         <a href="#rid13">
          13
         </a>
         ]. However, nebulizer performance can vary greatly based upon a number of factors  (
         <a class="graphic graphic_table graphicRef58515" href="/z/d/graphic/58515.html" rel="external">
          table 2
         </a>
         ). Conventional jet nebulizers are highly inefficient because of output lost during exhalation during normal breathing and because more than 90 percent of the primary droplets become trapped on the baffles or internal structures [
         <a href="#rid14">
          14
         </a>
         ]. In addition, conventional jet nebulizers produce a constant flow rate during aerosolization, leading to further drug wastage and inefficiency. Enhanced jet nebulizers have been designed that address specific delivery issues. (See
         <a class="local">
          'Enhanced jet nebulizer designs'
         </a>
         below.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Nebulization time
         </strong>
         – The majority of nebulized dose is delivered during the first five minutes in most cases [
         <a href="#rid15">
          15
         </a>
         ], and little additional benefit is gained by extending nebulization time beyond 5 to 10 minutes [
         <a href="#rid10">
          10
         </a>
         ]. Furthermore, aerosol output drops dramatically and further nebulization is unproductive once sputtering begins [
         <a href="#rid16">
          16
         </a>
         ]. Continuous nebulization is employed in the management of acute severe asthma in children and is discussed below. (See
         <a class="local">
          'Continuous nebulization'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Chamber design
         </strong>
         – Nebulizers vary widely in the ability to efficiently aerosolize medications and generate aerosol particles in the "respirable range," with total lung deposition of starting medication ranging from approximately 2 percent up to 20 percent or greater with more efficient nebulizers [
         <a href="#rid4">
          4,5,17,18
         </a>
         ]. The efficiency also varies as a function of patient age. As an example, the mean total lung deposition of
         <a class="drug drug_pediatric" data-topicid="13290" href="/z/d/drug information/13290.html" rel="external">
          albuterol
         </a>
         delivered using a breath-enhanced, open-vent-assisted nebulizer expressed as a percentage of starting dose was 5 percent in children younger than four years of age and 11 percent in children four to nine years of age [
         <a href="#rid18">
          18
         </a>
         ]. (See
         <a class="local">
          'Breath-enhanced open-vent nebulizer'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Driving gas
         </strong>
         – The fraction of particles in the respirable range also is altered by the flow rate of the driving air or oxygen, with flow rates of 8 liters per minute providing optimal mass median aerodynamic diameter (MMAD) of the aerosol particles, aerosol volumes, and nebulization times when using conventional small-volume nebulizers [
         <a href="#rid5">
          5,8,19
         </a>
         ]. For these nebulizers, decreasing the driving flow rate from 8 to 6 L/min may reduce the output of respirable particles by 25 to 30 percent [
         <a href="#rid20">
          20
         </a>
         ]. However, many home compressors are not capable of delivering flow rates this high, resulting in a larger MMAD of the aerosol particles. Alternatively, breath-enhanced nebulizers function efficiently at driving flow rates of 3 to 5 L/min, making them much more effective when used with home compressors [
         <a href="#rid21">
          21
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Such variances in output highlight the importance of trying to match recommended nebulizers and medical compressors for the medication being delivered, as indicated in package inserts. For instance, pivotal trials for
         <a class="drug drug_pediatric" data-topicid="13096" href="/z/d/drug information/13096.html" rel="external">
          budesonide
         </a>
         inhalation suspension used Pari nebulizers and compressors to provide optimal drug delivery. For some drugs, such as short-acting beta agonists, there are no recommendations for specific nebulizers or compressors. In addition, in the hospital setting, the set flow rate may not reflect the true flow exiting the nebulizer when using a dry gas source to drive the nebulizer. This can reduce the flow rate by up to 2 L/min due to inadequate back pressure compensation of the flow meter [
         <a href="#rid22">
          22
         </a>
         ] and may result in a larger MMAD and decreased pulmonary deposition of the aerosolized agent [
         <a href="#rid1">
          1,20
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         To avoid some of the variation in drug delivery seen with jet nebulizers, a suitable alternative for some medications is to switch to metered dose inhalers with valved-holding chambers. These devices are effective for the chronic delivery of inhaled glucocorticoids and the delivery of short-acting beta agonists in acute asthma, including in the emergency department setting. (See
         <a class="medical medical_review" href="/z/d/html/5738.html" rel="external">
          "The use of inhaler devices in children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Finally, the density of the gas powering the nebulizer affects nebulizer performance. As an example, the inhaled mass of
         <a class="drug drug_pediatric" data-topicid="13290" href="/z/d/drug information/13290.html" rel="external">
          albuterol
         </a>
         is significantly reduced when a nebulizer is powered with a mixture of 60 to 80 percent helium and 20 to 40 percent oxygen (heliox). Accordingly, the flow to the nebulizer should be doubled if it is powered with heliox [
         <a href="#rid23">
          23
         </a>
         ]. Heliox may improve aerosol delivery to the lower respiratory tract because the decrease in density results in the creation of smaller particles; however, the clinical benefit of this approach is unclear [
         <a href="#rid24">
          24-30
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/541.html" rel="external">
          "Physiology and clinical use of heliox"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Dead volume
         </strong>
         – Dead volume refers to the residual medication solution remaining in the nebulizer reservoir after therapy. This residual solution is incapable of activating further nebulization, and the amount can vary considerably between different nebulizer models [
         <a href="#rid17">
          17,31
         </a>
         ]. The concentration of drug within this dead volume is increased by the evaporation of the solute, such as normal
         <a class="drug drug_pediatric" data-topicid="12796" href="/z/d/drug information/12796.html" rel="external">
          saline
         </a>
         , during nebulization. This can lead to considerable drug wastage.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The amount of wasted drug can be reduced by adjusting the starting volume of nebulizer solution to at least 4 mL, an amount that generally can be administered within 10 minutes using flow rates of 8 L/min [
         <a href="#rid5">
          5,17
         </a>
         ]. Tapping on the nebulizer chamber during nebulization may further reduce dead volume.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Physical properties of the solution
         </strong>
         – The primary droplet size produced during nebulization is proportional to the viscosity and surface tension of the nebulized liquid, which increase as the solution cools during nebulization, potentially resulting in decreased output and longer nebulization times [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other factors
         </strong>
         – The level of cooperation of the patient [
         <a href="#rid32">
          32
         </a>
         ]; changes in breathing patterns, such as occurs with persistent cough; and type of facemask used [
         <a href="#rid33">
          33
         </a>
         ] may also impact drug delivery. In addition, the filters on the medical compressor units should be changed every approximately six months; failure to do so can affect performance.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h1">
          ENHANCED JET NEBULIZER DESIGNS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Enhancements to the design of jet nebulizers have improved performance and reduced aerosol waste during the exhalation phase  (
         <a class="graphic graphic_picture graphicRef56942" href="/z/d/graphic/56942.html" rel="external">
          picture 1
         </a>
         and
         <a class="graphic graphic_table graphicRef64982" href="/z/d/graphic/64982.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Breath-enhanced open-vent nebulizer
         </span>
         <span class="headingEndMark">
          —
         </span>
         Open-vent jet nebulizers incorporate an opening in the reservoir that allows the continuous entrainment of air during nebulization, resulting in increased airflow within the nebulizer chamber, smaller aerosol particle size, shorter nebulization times, and greater aerosol output during inspiration [
         <a href="#rid14">
          14,34
         </a>
         ]. However, these increased flows can result in greater drug loss during exhalation.
        </p>
        <p>
         The drug wastage of the open-vent jet nebulizer can be partially overcome by using a breath-enhanced system because these nebulizers entrain gas only during inspiration [
         <a href="#rid14">
          14,22
         </a>
         ]. Use of a breath-enhanced nebulizer may increase the delivered dose by as much as 20 to 50 percent [
         <a href="#rid34">
          34
         </a>
         ].
        </p>
        <p>
         Advantages of breath-enhanced, open-vent nebulizers include [
         <a href="#rid10">
          10,35,36
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Production of smaller particles in aerosol
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Faster nebulization rates as compared with conventional nebulizers
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Increased aerosol delivery to the patient with less wastage
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lower compressed airflow required
        </p>
        <p>
        </p>
        <p>
         The disadvantages of open-vent jet nebulizers are that they are dependent upon the patient's inspiratory flow rate and tidal volume for optimum function [
         <a href="#rid22">
          22
         </a>
         ] and they cost more than conventional nebulizers.
        </p>
        <p>
         These nebulizers have not been fully evaluated in infants and very young children, although they appear to be more efficient than the conventional nebulizers generally used in the management of this patient population [
         <a href="#rid37">
          37,38
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h2">
          Storage bag nebulizers
         </span>
         <span class="headingEndMark">
          —
         </span>
         Some nebulizers incorporate a storage bag with a one-way valve in the mouthpiece connector. Aerosol is collected in the bag during the expiratory phase and delivered to the patient on the subsequent inhalation, reducing medication waste.
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h2">
          Intermittent nebulizers
         </span>
         <span class="headingEndMark">
          —
         </span>
         Older intermittent nebulizers use a thumb control that allows the patient to manually cease gas flow to the nebulizer during exhalation, which greatly decreases drug wastage. However, these systems require good hand-breath coordination and increase nebulization times up to fourfold [
         <a href="#rid34">
          34
         </a>
         ], making them unsuitable for most young children.
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h2">
          Breath-actuated nebulizers
         </span>
         <span class="headingEndMark">
          —
         </span>
         Breath-actuated nebulizers generate aerosols in coordination with inspiration and are capable of delivering higher drug doses, although with longer nebulization times [
         <a href="#rid34">
          34,39
         </a>
         ]. These nebulizers are activated by a breath-actuated diaphragm at inspiratory flow rates as low as 15 L/min. A study of children presenting to an emergency department with acute asthma suggests that the delivery of a single dose of
         <a class="drug drug_pediatric" data-topicid="13290" href="/z/d/drug information/13290.html" rel="external">
          albuterol
         </a>
         using a breath-actuated nebulizer (AeroEclipse)  (
         <a class="graphic graphic_picture graphicRef56942" href="/z/d/graphic/56942.html" rel="external">
          picture 1
         </a>
         ) is more effective than a single dose or one hour of continuous albuterol administration using a conventional jet nebulizer [
         <a href="#rid40">
          40
         </a>
         ]. Of note, children as young as six months of age were able to breath-actuate the nebulizer, although a few initially required manual activation for four to six breaths due to their high clinical respiratory scores.
        </p>
        <p class="headingAnchor" id="H4149763874">
         <span class="h1">
          AEROSOL DELIVERY IN SPECIAL SITUATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H2348736993">
         <span class="h2">
          Mixing nebulized medications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Some patients need more than one nebulized medication, such as one or more bronchodilators or a bronchodilator plus glucocorticoid or hypertonic
         <a class="drug drug_pediatric" data-topicid="12796" href="/z/d/drug information/12796.html" rel="external">
          saline
         </a>
         . Certain preparations are compatible and can be mixed into a single nebulizer treatment, thus improving patient convenience. However, caution is necessary as certain mixtures are incompatible due to changes in particle size or other characteristics. As an example, hypertonic sodium chloride is compatible with
         <a class="drug drug_pediatric" data-topicid="13096" href="/z/d/drug information/13096.html" rel="external">
          budesonide
         </a>
         , but not with
         <a class="drug drug_pediatric" data-topicid="13290" href="/z/d/drug information/13290.html" rel="external">
          albuterol
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="13324" href="/z/d/drug information/13324.html" rel="external">
          formoterol
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="13389" href="/z/d/drug information/13389.html" rel="external">
          ipratropium
         </a>
         , or
         <a class="drug drug_pediatric" data-topicid="13319" href="/z/d/drug information/13319.html" rel="external">
          fluticasone
         </a>
         . A listing of compatible and incompatible solutions is provided in the table  (
         <a class="graphic graphic_table graphicRef122909" href="/z/d/graphic/122909.html" rel="external">
          table 3
         </a>
         ).
        </p>
        <p>
         When mixing nebulized medications, freshly opened, single-use formulations should be used.
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h2">
          Nebulizers for specific medications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Specially constructed small-volume nebulizers with closed scavenging systems were developed to prevent potentially toxic aerosolized medications from entering the general environment [
         <a href="#rid7">
          7
         </a>
         ]. The Respirgard II for aerosolized
         <a class="drug drug_pediatric" data-topicid="12690" href="/z/d/drug information/12690.html" rel="external">
          pentamidine
         </a>
         , for example, is fitted with one-way valves and filters to minimize gross contamination of the environment.
        </p>
        <p>
         A separate device was developed to allow the safe delivery of aerosolized
         <a class="drug drug_pediatric" data-topicid="12764" href="/z/d/drug information/12764.html" rel="external">
          ribavirin
         </a>
         , which is potentially teratogenic. The Small-Particle Aerosol Generator (SPAG) was designed specifically to aerosolize ribavirin. It consists of a jet nebulizer and drying chamber that together reduce the mass median aerodynamic diameter (MMAD) to a mean of 1.3 micrometers, which optimizes drug delivery to distal airspaces. The SPAG is used with a scavenging system to minimize contamination of the ambient environment.
        </p>
        <p>
         Other medication solutions for nebulization, including DNase I (dornase alfa, Pulmozyme; Hudson, Marquest, and Pari LC nebulizers),
         <a class="drug drug_pediatric" data-topicid="12845" href="/z/d/drug information/12845.html" rel="external">
          tobramycin
         </a>
         (TOBI; Pari LC Plus nebulizer), and
         <a class="drug drug_pediatric" data-topicid="12949" href="/z/d/drug information/12949.html" rel="external">
          aztreonam
         </a>
         (Cayston; Altera nebulizer) should only be delivered using nebulizers specifically approved by the drug manufacturer for use with these agents. Results may not be the same if other nebulizers are used instead of those studied with the drug.
        </p>
        <p class="headingAnchor" id="H1352583">
         <span class="h2">
          Continuous nebulization
         </span>
         <span class="headingEndMark">
          —
         </span>
         Beta agonists are commonly administered as a continuously nebulized aerosol in children with severe asthma exacerbations  (
         <a class="graphic graphic_table graphicRef134102" href="/z/d/graphic/134102.html" rel="external">
          table 4
         </a>
         ). Multiple studies have demonstrated the efficacy and safety of this technique, even when high doses (eg, 20 mg/hour of
         <a class="drug drug_pediatric" data-topicid="13290" href="/z/d/drug information/13290.html" rel="external">
          albuterol
         </a>
         ) are used [
         <a href="#rid41">
          41-46
         </a>
         ]. In addition, drug delivery over time by continuous nebulization appears similar to that with frequent intermittent nebulization but potentially with a reduction in medical personnel time and costs of therapy [
         <a href="#rid47">
          47
         </a>
         ]. However, studies of continuous nebulization versus intermittent nebulization are uncontrolled and lack objective data (ie, pulmonary function) to support the use of one method over the other.
        </p>
        <p>
         Continuous nebulization requires a special delivery system to avoid the need for refilling the standard nebulizer every 10 to 15 minutes. Several strategies have been employed for administering continuously nebulized aerosols:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A small- or medium-volume nebulizer may be fitted with an intravenous infusion pump that drips premixed bronchodilator solution into the nebulizer chamber [
         <a href="#rid13">
          13,44,48
         </a>
         ]. A simple set-up is used in the nonventilated patient  (
         <a class="graphic graphic_figure graphicRef86236" href="/z/d/graphic/86236.html" rel="external">
          figure 3
         </a>
         ), but a more complicated set-up is required in the patient on mechanical ventilation  (
         <a class="graphic graphic_figure graphicRef73109" href="/z/d/graphic/73109.html" rel="external">
          figure 4
         </a>
         ). This is the preferred method at the author's institution for the nonventilated patient (due to cost and desire to limit inventories and devices). For the patient on mechanical ventilation, the author's institution uses a small-particle-generating vibratory mesh nebulizer positioned on the dry side of the humidifier.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A large-volume nebulizer that can generate approximately 30 mL/hour of aerosol can be used in the nonventilated patient  (
         <a class="graphic graphic_picture graphicRef83685" href="/z/d/graphic/83685.html" rel="external">
          picture 2
         </a>
         ) [
         <a href="#rid13">
          13
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Continuous aerosolized
         <a class="drug drug_pediatric" data-topicid="13290" href="/z/d/drug information/13290.html" rel="external">
          albuterol
         </a>
         also can be delivered effectively using a mixture of helium and oxygen (Heliox), although a higher driving flow rate (11 L/min) should be used [
         <a href="#rid23">
          23
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/541.html" rel="external">
          "Physiology and clinical use of heliox"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h1">
          USING A JET NEBULIZER
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients and caregivers should receive explicit instruction on the appropriate use of jet nebulizers  (
         <a class="graphic graphic_table graphicRef71696" href="/z/d/graphic/71696.html" rel="external">
          table 5
         </a>
         ). Several technical factors complicate the use of these devices in the home. (See
         <a class="medical medical_review" href="/z/d/html/5737.html" rel="external">
          "Delivery of inhaled medication in children"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h2">
          Compressors for home use
         </span>
         <span class="headingEndMark">
          —
         </span>
         The use of jet nebulizers in the home requires a compressor to generate the driving airflow. However, commercial compressors vary widely in the flow rates they generate, and different nebulizer/compressor combinations may have marked differences in how efficiently they generate respirable output [
         <a href="#rid13">
          13,21,49
         </a>
         ]. Compressors generating flow rates that are too low to drive a given nebulizer will result in negligible respirable output and ineffective therapy [
         <a href="#rid13">
          13
         </a>
         ].
        </p>
        <p>
         Only those nebulizer/compressor combinations that are known to deliver at least 50 percent of each ordered drug as respirable particles within 10 minutes should be prescribed [
         <a href="#rid13">
          13,49
         </a>
         ]. The standard compressor used in many studies of nebulizer performance in the United States is the DeVilbiss Pulmo-Aide compressor, which is specified for use when administering aerosolized
         <a class="drug drug_pediatric" data-topicid="12845" href="/z/d/drug information/12845.html" rel="external">
          tobramycin
         </a>
         (TOBI) [
         <a href="#rid22">
          22,50,51
         </a>
         ]. Unfortunately, there are no minimal standards for nebulizer/compressor performance in North America, although such standards do exist in Europe [
         <a href="#rid1">
          1,13
         </a>
         ]. Most compressors for home use have a five-year warranty.
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h2">
          Infection control
         </span>
         <span class="headingEndMark">
          —
         </span>
         Repeated use of disposable nebulizers may lead to bacterial contamination and nosocomial infection [
         <a href="#rid52">
          52-55
         </a>
         ]. Home nebulizers meant for longer-term use also are frequently contaminated with bacteria, but standardized guidelines for disinfecting home nebulizers are not available [
         <a href="#rid56">
          56
         </a>
         ]. At a minimum, home nebulizers should be cleaned by rinsing and air-dried between uses to prevent clogging of the Venturi and to reduce microbial contamination [
         <a href="#rid13">
          13
         </a>
         ]. It is also recommended that nebulizers be disinfected by soaking one to two times per week in an acetic acid solution for 30 minutes (one part distilled white vinegar to three parts warm water) or in a commercial quaternary ammonium compound for 10 minutes, although even these measures may not provide adequate sterilization [
         <a href="#rid56">
          56,57
         </a>
         ]. The final rinse should be with tap water. Home nebulizers and the compressor filter should be replaced every six months. (See
         <a class="medical medical_review" href="/z/d/html/4042.html" rel="external">
          "Infection prevention: Precautions for preventing transmission of infection"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h2">
          Allergen control
         </span>
         <span class="headingEndMark">
          —
         </span>
         The reservoirs of home nebulizers also may be contaminated by indoor allergens. In one study, the reservoirs of 5 of 17 nebulizers collected from the homes of children with asthma were contaminated by at least one antigen (cockroach, cat, dog, mouse) [
         <a href="#rid58">
          58
         </a>
         ]. Proper cleaning of nebulizers, as described above, and storage of nebulizers in plastic bags may prevent contamination with allergens.
        </p>
        <p class="headingAnchor" id="H1352407">
         <span class="h2">
          Performance deterioration
         </span>
         <span class="headingEndMark">
          —
         </span>
         There is some potential for performance deterioration of nebulizers used at home repeatedly over time [
         <a href="#rid59">
          59,60
         </a>
         ], although this risk appears minimal if these units are properly maintained and rinsed between uses [
         <a href="#rid61">
          61
         </a>
         ]. The replacement time interval is based upon the manufacturer's recommendation for each specific nebulizer but should not exceed six months. The tubing is generally supplied with the nebulizer cup and should be changed at the same time.
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (see
         <a class="medical medical_patient" href="/z/d/html/1222.html" rel="external">
          "Patient education: Asthma symptoms and diagnosis in children (Beyond the Basics)"
         </a>
         and
         <a class="medical medical_patient" href="/z/d/html/1172.html" rel="external">
          "Patient education: Asthma treatment in children (Beyond the Basics)"
         </a>
         and
         <a class="medical medical_patient" href="/z/d/html/1173.html" rel="external">
          "Patient education: Asthma inhaler techniques in children (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4042862">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Nebulizers are used to provide aerosol therapy to patients too ill or too young to use handheld devices and in situations where large drug doses and combination therapy are necessary. These devices also are required for some medications available only in aerosol form. (See
         <a class="local">
          'Indications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         There are three basic types of nebulizers: jet nebulizers, ultrasonic nebulizers, and vibrating mesh nebulizers  (
         <a class="graphic graphic_table graphicRef64982" href="/z/d/graphic/64982.html" rel="external">
          table 1
         </a>
         ) (see
         <a class="local">
          'Basic types of nebulizers'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Jet nebulizers  (
         <a class="graphic graphic_figure graphicRef75397" href="/z/d/graphic/75397.html" rel="external">
          figure 1
         </a>
         ) are the most commonly used form of nebulizer due to their lower cost and comparable clinical efficacy in many situations.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Ultrasonic nebulizers can nebulize large volumes of liquid more quickly and, unlike jet nebulizers, do not require a source of driving gas. However, particle sizes may be larger with these devices, and the high-density aerosols generated are associated with bronchospasm and increased airway resistance in some patients. In addition, ultrasonic nebulizers do not nebulize suspensions efficiently and potentially could break down complex molecules, reducing their effect.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Vibrating mesh nebulizers  (
         <a class="graphic graphic_figure graphicRef69736" href="/z/d/graphic/69736.html" rel="external">
          figure 2
         </a>
         ) are more efficient than other conventional nebulizers but are also more costly and must be disassembled and cleaned after each use to prevent clogging of the pores within the membrane. They are generally selected for use with expensive medications to minimize drug waste.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Factors that can affect jet nebulizer performance include nebulization time, chamber design, driving gas used, dead volume, and physical properties of the solution or suspension. (See
         <a class="local">
          'Factors affecting jet nebulizer performance'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Enhancements to the design of jet nebulizers have improved performance and reduced aerosol waste during the exhalation phase  (
         <a class="graphic graphic_picture graphicRef56942" href="/z/d/graphic/56942.html" rel="external">
          picture 1
         </a>
         ). These types include breath-enhanced open-vent, storage bag, intermittent, and breath-actuated nebulizers. (See
         <a class="local">
          'Enhanced jet nebulizer designs'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Specially constructed small-volume nebulizers with closed scavenging systems were developed to prevent potentially toxic aerosolized medications from entering the general environment. (See
         <a class="local">
          'Nebulizers for specific medications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beta agonists are commonly administered as a continuously nebulized aerosol in children with severe asthma exacerbations in emergency departments and inpatient units. Continuous nebulization requires a special delivery system to avoid the need for refilling the standard, small-volume nebulizer every 10 to 15 minutes  (
         <a class="graphic graphic_figure graphicRef73109" href="/z/d/graphic/73109.html" rel="external">
          figure 4
         </a>
         and
         <a class="graphic graphic_figure graphicRef86236" href="/z/d/graphic/86236.html" rel="external">
          figure 3
         </a>
         ). (See
         <a class="local">
          'Continuous nebulization'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients and caregivers should receive explicit instruction on the appropriate use of jet nebulizers  (
         <a class="graphic graphic_table graphicRef71696" href="/z/d/graphic/71696.html" rel="external">
          table 5
         </a>
         ). Several technical factors complicate the use of these devices in the home, including the ability of the compress to deliver sufficient flow rate and infection and allergen control. Drug delivery can be improved with several simple measures, such as increasing the fill volume to at least 4 mL and warming the solution. (See
         <a class="local">
          'Using a jet nebulizer'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Coates AL, Ho SL. Drug administration by jet nebulization. Pediatr Pulmonol 1998; 26:412.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Donohue WJ Jr. Guidelines for the use of nebulizers in the home and at domiciliary sites. Report of a consensus conference. National Association for Medical Direction of Respiratory Care (NAMDRC) Consensus Group. Chest 1996; 109:814.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dolovich MA, MacIntyre NR, Anderson PJ, et al. Consensus statement: aerosols and delivery devices. American Association for Respiratory Care. Respir Care 2000; 45:589.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hardy JG, Newman SP, Knoch M. Lung deposition from four nebulizers. Respir Med 1993; 87:461.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hess D, Fisher D, Williams P, et al. Medication nebulizer performance. Effects of diluent volume, nebulizer flow, and nebulizer brand. Chest 1996; 110:498.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stanford G, Morrison L, Brown C. Nebuliser systems for drug delivery in cystic fibrosis. Cochrane Database Syst Rev 2023; 11:CD007639.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hess DR. Nebulizers: principles and performance. Respir Care 2000; 45:609.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clay MM, Pavia D, Newman SP, Clarke SW. Factors influencing the size distribution of aerosols from jet nebulisers. Thorax 1983; 38:755.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kendrick AH, Smith EC. Optimizing nebulization practice. Respir Med 1996; 90:315.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Callaghan C, Barry PW. The science of nebulised drug delivery. Thorax 1997; 52 Suppl 2:S31.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bucholski A, Keller M, Balcke A, et al. In vitro performance of eFlowTM, an electronic inhaler for administration of a novel aztreonam formulation to CF patients. Pediatr Pulmonol Suppl 2003; 25:321.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lass JS, Sant A, Knoch M. New advances in aerosolised drug delivery: vibrating membrane nebuliser technology. Expert Opin Drug Deliv 2006; 3:693.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rubin BK, Fink JB. Aerosol therapy for children. Respir Care Clin N Am 2001; 7:175.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Callaghan C, Barry PW. Asthma drug delivery devices for children. BMJ 2000; 320:664.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Callaghan C, Clark AR, Milner AD. Why nebulise for more than five minutes? Arch Dis Child 1989; 64:1270.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Malone RA, Hollie MC, Glynn-Barnhart A, Nelson HS. Optimal duration of nebulized albuterol therapy. Chest 1993; 104:1114.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dennis JH, Hendrick DJ. Design characteristics for drug nebulizers. J Med Eng Technol 1992; 16:63.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wildhaber JH, Dore ND, Wilson JM, et al. Inhalation therapy in asthma: nebulizer or pressurized metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children. J Pediatr 1999; 135:28.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clay MM, Pavia D, Newman SP, et al. Assessment of jet nebulisers for lung aerosol therapy. Lancet 1983; 2:592.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coates AL, MacNeish CF, Meisner D, et al. The choice of jet nebulizer, nebulizing flow, and addition of albuterol affects the output of tobramycin aerosols. Chest 1997; 111:1206.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reisner C, Katial RK, Bartelson BB, et al. Characterization of aerosol output from various nebulizer/compressor combinations. Ann Allergy Asthma Immunol 2001; 86:566.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coates AL, MacNeish CF, Lands LC, et al. A comparison of the availability of tobramycin for inhalation from vented vs unvented nebulizers. Chest 1998; 113:951.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hess DR, Acosta FL, Ritz RH, et al. The effect of heliox on nebulizer function using a beta-agonist bronchodilator. Chest 1999; 115:184.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kress JP, Noth I, Gehlbach BK, et al. The utility of albuterol nebulized with heliox during acute asthma exacerbations. Am J Respir Crit Care Med 2002; 165:1317.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Henderson SO, Acharya P, Kilaghbian T, et al. Use of heliox-driven nebulizer therapy in the treatment of acute asthma. Ann Emerg Med 1999; 33:141.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anderson M, Svartengren M, Philioson K, et al. Deposition in man of particles suspended in air or in helium-oxygen mixture at different flow rates. J Aerosol Med 1990; 3:209.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anderson M, Svartengren M, Bylin G, et al. Deposition in asthmatics of particles inhaled in air or in helium-oxygen. Am Rev Respir Dis 1993; 147:524.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Habib DM, Garner SS, Brandeburg S. Effect of helium-oxygen on delivery of albuterol in a pediatric, volume-cycled, ventilated lung model. Pharmacotherapy 1999; 19:143.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Svartengren M, Anderson M, Philipson K, Camner P. Human lung deposition of particles suspended in air or in helium/oxygen mixture. Exp Lung Res 1989; 15:575.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bigham MT, Jacobs BR, Monaco MA, et al. Helium/oxygen-driven albuterol nebulization in the management of children with status asthmaticus: a randomized, placebo-controlled trial. Pediatr Crit Care Med 2010; 11:356.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ho SL, Coates AL. Effect of dead volume on the efficiency and the cost to deliver medications in cystic fibrosis with four disposable nebulizers. Can Respir J 1999; 6:253.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schueepp KG, Devadason SG, Roller C, et al. Aerosol delivery of nebulised budesonide in young children with asthma. Respir Med 2009; 103:1738.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kundoor V, Dalby RN. Assessment of facial and ocular deposition of nebulized aerosol using a color-based method. Drug Dev Ind Pharm 2010; 36:1281.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fink JB. Aerosol device selection: evidence to practice. Respir Care 2000; 45:874.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barry PW, O'Callaghan C. An in vitro analysis of the output of budesonide from different nebulizers. J Allergy Clin Immunol 1999; 104:1168.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barry PW, O'Callaghan C. An in vitro analysis of the output of salbutamol from different nebulizers. Eur Respir J 1999; 13:1164.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Devadason SG, Everard ML, Linto JM, Le Souëf PN. Comparison of drug delivery from conventional versus "Venturi" nebulizers. Eur Respir J 1997; 10:2479.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wildhaber JH, Devadason SG, Eber E, et al. Effect of electrostatic charge, flow, delay and multiple actuations on the in vitro delivery of salbutamol from different small volume spacers for infants. Thorax 1996; 51:985.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nikander K, Agertoft L, Pedersen S. Breath-synchronized nebulization diminishes the impact of patient-device interfaces (face mask or mouthpiece) on the inhaled mass of nebulized budesonide. J Asthma 2000; 37:451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sabato K, Ward P, Hawk W, et al. Randomized controlled trial of a breath-actuated nebulizer in pediatric asthma patients in the emergency department. Respir Care 2011; 56:761.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Papo MC, Frank J, Thompson AE. A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children. Crit Care Med 1993; 21:1479.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Katz RW, Kelly HW, Crowley MR, et al. Safety of continuous nebulized albuterol for bronchospasm in infants and children. Pediatrics 1993; 92:666.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moler FW, Johnson CE, Van Laanen C, et al. Continuous versus intermittent nebulized terbutaline: plasma levels and effects. Am J Respir Crit Care Med 1995; 151:602.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moler FW, Hurwitz ME, Custer JR. Improvement in clinical asthma score and PaCO2 in children with severe asthma treated with continuously nebulized terbutaline. J Allergy Clin Immunol 1988; 81:1101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Portnoy J, Nadel G, Amado M, Willsie-Ediger S. Continuous nebulization for status asthmaticus. Ann Allergy 1992; 69:71.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Portnoy J, Aggarwal J. Continuous terbutaline nebulization for the treatment of severe exacerbations of asthma in children. Ann Allergy 1988; 60:368.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McPeck M, Tandon R, Hughes K, Smaldone GC. Aerosol delivery during continuous nebulization. Chest 1997; 111:1200.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Voss KR, Willsie-Ediger SK, Pyszczynski DR, Nelson KA. Description of a delivery method for continuously aerosolized albuterol in status asthmaticus. J Asthma 1990; 27:37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berg EB, Picard RJ. In vitro delivery of budesonide from 30 jet nebulizer/compressor combinations using infant and child breathing patterns. Respir Care 2009; 54:1671.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Loffert DT, Ikle D, Nelson HS. A comparison of commercial jet nebulizers. Chest 1994; 106:1788.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Standaert TA, Vandevanter D, Ramsey BW, et al. The choice of compressor effects the aerosol parameters and the delivery of tobramycin from a single model nebulizer. J Aerosol Med 2000; 13:147.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jakobsson BM, Onnered AB, Hjelte L, Nyström B. Low bacterial contamination of nebulizers in home treatment of cystic fibrosis patients. J Hosp Infect 1997; 36:201.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hutchinson GR, Parker S, Pryor JA, et al. Home-use nebulizers: a potential primary source of Burkholderia cepacia and other colistin-resistant, gram-negative bacteria in patients with cystic fibrosis. J Clin Microbiol 1996; 34:584.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wexler MR, Rhame FS, Blumenthal MN, et al. Transmission of gram-negative bacilli to asthmatic children via home nebulizers. Ann Allergy 1991; 66:267.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guideline for prevention of nosocomial pneumonia. Centers for Disease Control and Prevention. Respir Care 1994; 39:1191.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenfeld M, Emerson J, Astley S, et al. Home nebulizer use among patients with cystic fibrosis. J Pediatr 1998; 132:125.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chatburn RL, Kallstrom TJ, Bajaksouzian SA. A comparison of acetic acid with a quaternary ammonium compound for disinfection of hand-held nebulizers. Respir Care 1988; 33:179.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bollinger ME, Butz A, Mudd K, Hamilton RG. Contamination of nebulizers with environmental allergens. Ann Allergy Asthma Immunol 2005; 95:429.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alvine GF, Rodgers P, Fitzsimmons KM, Ahrens RC. Disposable jet nebulizers. How reliable are they? Chest 1992; 101:316.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coates AL, Canny G, Zinman R, et al. The effects of chronic airflow limitation, increased dead space, and the pattern of ventilation on gas exchange during maximal exercise in advanced cystic fibrosis. Am Rev Respir Dis 1988; 138:1524.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Standaert TA, Morlin GL, Williams-Warren J, et al. Effects of repetitive use and cleaning techniques of disposable jet nebulizers on aerosol generation. Chest 1998; 114:577.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5736 Version 15.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9888216" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Drug administration by jet nebulization.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8617094" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Guidelines for the use of nebulizers in the home and at domiciliary sites. Report of a consensus conference. National Association for Medical Direction of Respiratory Care (NAMDRC) Consensus Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10894452" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Consensus statement: aerosols and delivery devices. American Association for Respiratory Care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8210617" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Lung deposition from four nebulizers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8697857" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Medication nebulizer performance. Effects of diluent volume, nebulizer flow, and nebulizer brand.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37942828" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Nebuliser systems for drug delivery in cystic fibrosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10894454" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Nebulizers: principles and performance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6648854" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Factors influencing the size distribution of aerosols from jet nebulisers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9499817" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Optimizing nebulization practice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9155849" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : The science of nebulised drug delivery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : In vitro performance of eFlowTM, an electronic inhaler for administration of a novel aztreonam formulation to CF patients
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16948564" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : New advances in aerosolised drug delivery: vibrating membrane nebuliser technology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11517020" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Aerosol therapy for children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10710559" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Asthma drug delivery devices for children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2510610" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Why nebulise for more than five minutes?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8404177" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Optimal duration of nebulized albuterol therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1404307" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Design characteristics for drug nebulizers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10393600" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Inhalation therapy in asthma: nebulizer or pressurized metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6136746" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Assessment of jet nebulisers for lung aerosol therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9149571" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : The choice of jet nebulizer, nebulizing flow, and addition of albuterol affects the output of tobramycin aerosols.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11379809" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Characterization of aerosol output from various nebulizer/compressor combinations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9554630" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : A comparison of the availability of tobramycin for inhalation from vented vs unvented nebulizers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9925082" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : The effect of heliox on nebulizer function using a beta-agonist bronchodilator.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11991886" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : The utility of albuterol nebulized with heliox during acute asthma exacerbations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9922408" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Use of heliox-driven nebulizer therapy in the treatment of acute asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Deposition in man of particles suspended in air or in helium-oxygen mixture at different flow rates
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8442582" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Deposition in asthmatics of particles inhaled in air or in helium-oxygen.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10030764" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Effect of helium-oxygen on delivery of albuterol in a pediatric, volume-cycled, ventilated lung model.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2670533" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Human lung deposition of particles suspended in air or in helium/oxygen mixture.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20464778" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Helium/oxygen-driven albuterol nebulization in the management of children with status asthmaticus: a randomized, placebo-controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10393287" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Effect of dead volume on the efficiency and the cost to deliver medications in cystic fibrosis with four disposable nebulizers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19540100" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Aerosol delivery of nebulised budesonide in young children with asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20545511" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Assessment of facial and ocular deposition of nebulized aerosol using a color-based method.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10926386" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Aerosol device selection: evidence to practice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10588997" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : An in vitro analysis of the output of budesonide from different nebulizers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10414421" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : An in vitro analysis of the output of salbutamol from different nebulizers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9426082" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Comparison of drug delivery from conventional versus "Venturi" nebulizers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8977597" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Effect of electrostatic charge, flow, delay and multiple actuations on the in vitro delivery of salbutamol from different small volume spacers for infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10983623" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Breath-synchronized nebulization diminishes the impact of patient-device interfaces (face mask or mouthpiece) on the inhaled mass of nebulized budesonide.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21333060" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Randomized controlled trial of a breath-actuated nebulizer in pediatric asthma patients in the emergency department.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8403956" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8414852" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Safety of continuous nebulized albuterol for bronchospasm in infants and children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7881645" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Continuous versus intermittent nebulized terbutaline: plasma levels and effects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3132498" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Improvement in clinical asthma score and PaCO2 in children with severe asthma treated with continuously nebulized terbutaline.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1626763" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Continuous nebulization for status asthmaticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3128951" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Continuous terbutaline nebulization for the treatment of severe exacerbations of asthma in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9149570" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Aerosol delivery during continuous nebulization.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2307646" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Description of a delivery method for continuously aerosolized albuterol in status asthmaticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19961633" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : In vitro delivery of budesonide from 30 jet nebulizer/compressor combinations using infant and child breathing patterns.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7988201" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : A comparison of commercial jet nebulizers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11010595" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : The choice of compressor effects the aerosol parameters and the delivery of tobramycin from a single model nebulizer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9253701" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Low bacterial contamination of nebulizers in home treatment of cystic fibrosis patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8904419" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Home-use nebulizers: a potential primary source of Burkholderia cepacia and other colistin-resistant, gram-negative bacteria in patients with cystic fibrosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2006776" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Transmission of gram-negative bacilli to asthmatic children via home nebulizers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10146141" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Guideline for prevention of nosocomial pneumonia. Centers for Disease Control and Prevention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9470013" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Home nebulizer use among patients with cystic fibrosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : A comparison of acetic acid with a quaternary ammonium compound for disinfection of hand-held nebulizers
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16315368" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Contamination of nebulizers with environmental allergens.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1735247" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Disposable jet nebulizers. How reliable are they?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3144220" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : The effects of chronic airflow limitation, increased dead space, and the pattern of ventilation on gas exchange during maximal exercise in advanced cystic fibrosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9726748" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Effects of repetitive use and cleaning techniques of disposable jet nebulizers on aerosol generation.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
